The Annals of Thoracic Surgery, Vol 28, 212-223, Copyright © 1979 by The Society of Thoracic Surgeons
Improved immunosuppression for cardiac transplantation: immune monitoring and individualized modulation of recipient immunity by in vitro testing
FT Thomas, SS Szentpetery, TC Wolfgang, JE Quinn, J Thomas and RR Lower
These studies demonstrate that immune monitoring and individualized
modulation of recipient immune reactivity using a quality-controlled
preparation of rabbit antithymocyte globulin can improve results of cardiac
transplantation. The most valuable assay in individualizing drug doses was
the serial measurement of T-cell levels using a complete lymphocyte profile
technique and monitoring with phytohemagglutinin to rule out false low
T-cell levels. Using this system, the incidence and severity of early
rejections were markedly reduced and no grafts were lost to rejection in
the first month. The recent first-year graft survival has been about 60%,
an improvement largely related to a reduction in early rejection and
infection. This technique of immunosuppression appears quite promising for
improving the results of future cardiac transplantations.